Amikacin Monotherapy for Treatment of Febrile Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase-producing Escherichia coli in Children

被引：13
|
作者：
Polat, Meltem [1 ]
Tapisiz, Anil [2 ]
机构：
[1] Pamukkale Univ, Sch Med, Dept Pediat Infect Dis, Denizli, Turkey
[2] Gazi Univ, Sch Med, Dept Pediat Infect Dis, Ankara, Turkey
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2018年 / 37卷 / 04期
关键词：
D O I：
10.1097/INF.0000000000001860
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：378 / 379
页数：2
相关论文
共 50 条
  • [31] Urinary tract infection caused by community-acquired extended-spectrum β-lactamase-producing bacteria in infants
    Kim, Yun Hee
    Yang, Eun Mi
    Kim, Chan Jong
    JORNAL DE PEDIATRIA, 2017, 93 (03) : 260 - 266
  • [32] Risk factors for and outcomes of bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species in children
    Zaoutis, TE
    Goyal, M
    Chu, JH
    Coffin, SE
    Bell, LM
    Nachamkin, I
    McGowan, KL
    Bilker, WB
    Lautenbach, E
    PEDIATRICS, 2005, 115 (04) : 942 - 949
  • [33] Urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and antibiotic resistance
    Albaramki, Jumana H.
    Abdelghani, Tariq
    Dalaeen, Alaa
    Ahmad, Fareed Khdair
    Alassaf, Abeer
    Odeh, Rasha
    Akl, Kamal
    PEDIATRICS INTERNATIONAL, 2019, 61 (11) : 1127 - 1132
  • [34] Potential Role of Fosfomycin in the Treatment of Community-Acquired Lower Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli
    Wilson, Dustin T.
    May, D. Byron
    AMERICAN JOURNAL OF THERAPEUTICS, 2013, 20 (06) : 685 - 690
  • [35] Retrospective evaluation of appropriate dosing of cefmetazole for invasive urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli
    Hamada, Yukihiro
    Matsumura, Yasufumi
    Nagashima, Maki
    Akazawa, Tsubasa
    Doi, Yohei
    Hayakawa, Kayoko
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (11) : 1602 - 1606
  • [36] Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli
    Ena, Javier
    Arjona, Francisco
    Martinez-Peinado, Carmen
    Lopez-Perezagua, Maria Del Mar
    Amador, Concepcion
    UROLOGY, 2006, 68 (06) : 1169 - 1174
  • [37] Emergence of extended-spectrum β-lactamase-producing Escherichia coli in catheter-associated urinary tract infection in neurogenic bladder patients
    Takaba, Kei
    Shigemura, Katsumi
    Osawa, Kayo
    Nomi, Masashi
    Fujisawa, Masato
    Arakawa, Soichi
    AMERICAN JOURNAL OF INFECTION CONTROL, 2014, 42 (03) : E29 - E31
  • [38] Therapeutic Options for Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli Reply
    Rodriguez-Bano, Jesus
    Pascual, Alvaro
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (01) : 120 - 121
  • [39] Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing enterobacteriaceae
    Kim, Se Ah
    Altshuler, Jerry
    Paris, Daryl
    Fedorenko, Marianna
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (01) : 155 - 158
  • [40] A clinical prediction tool for extended-spectrum β-lactamase-producing Enterobacteriaceae urinary tract infection
    Liu, Hui
    Qiu, Suishan
    Chen, Minghao
    Lyu, Jun
    Yu, Guangchao
    Xue, Lianfang
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
12345